Patent Grant
11191536
Staples exist for a variety of applications in the medical field. There are staples that may fix soft tissues, boney tissues, and soft tissues to boney tissues. Some staples may bring two or more tissues together while the staples are applied. Alternatively, staples may function to fix together some tissues that are brought together by other means, such as by mechanical or chemical means (shape memory).
In some applications, staples may be designed to bring tissues together so the tissues may heal. In some alternative applications, one or more staples may be used to hold or otherwise affix an instrument or other structure to one or more tissues. In some instances, however, an instrument or structure may not be adapted to work with a staple due to size or geometry.
Such medical staples may find use in a number of surgical or non-surgical procedures including, without limitation, an open surgical procedure, an arthroscopic procedure, or in less invasive procedures. Additionally, staples may include additional features suited to specialty applications including imaging applications, such as radiographic procedures.
In an embodiment, a device for securing an article to a tissue may be composed of a body, transitionable from a first deployment state to a second securing state, having a first portion, a second portion, and a medial portion between the first portion and the second portion, in which the first portion has a first terminal end configured to pierce the tissue, and in which the second securing state comprises at least a section of the first portion of the body assuming a curved geometry embedded in the tissue and at least a section of the medial portion of the body contacting a surface of the article.
In an embodiment, a device for securing an article to a tissue may be composed of a body, transitionable from a first deployment state to a second securing state, having a first portion, a second portion, and a medial portion between the first portion and the second portion, in which the first portion has a first terminal end configured to pierce the tissue, and a tab standoff in mechanical communication with the medial portion of the body at a first end and a tab at a second end, in which the tab is displaced by a slot from the body. The first deployment state of the device may be a linearly extended state. In the second securing state, the device has at least a section of the first portion of the body assuming a curved geometry embedded in the tissue and at least a section of the second portion contacting a surface of the article.
In an embodiment, a device for securing an article to a tissue may be compose of a body, transitionable from a first deployment state to a second securing state, having a first portion, a second portion, and a medial portion between the first portion and the second portion, in which the first portion has a first terminal end configured to pierce the tissue and the second portion has a second terminal end configured to pierce the tissue. The first deployment state may be a U-shaped state. In the second securing state, the device has at least a section of the first terminal end assuming a curved geometry embedded in the tissue, at least a section of the second terminal end assuming a curved geometry embedded in the tissue, and at least a section of the medial portion contacting a surface of the article.
In an embodiment, system for securing an article to a tissue by releasably engaging at least one securing device may be composed of an exterior tube having a distal end, in which at least a portion of the distal end of the exterior tube is configured to form a stable mechanical contact between the article and the tissue, and a push rod at least partially disposed within the interior tube. The system may be configured to releasably engage at least one securing device having a body transitionable from a first deployment state to a second securing state, and the push rod may be configured to effect a release of the at least one securing device, thereby allowing the securing device body to transition from the first deployment state to the second securing state.
In an embodiment, a method of securing an article to a tissue, may be composed of providing a system for securing the article to the tissue, the system composed of a housing having a distal end, in which at least a portion of the distal end of the housing is configured to engage the article with a surface of the tissue, providing at least one securing device composed of a body, transitionable from a first deployment state to a second securing state, having a first portion, a second portion, and a medial portion between the first portion and the second portion, in which the first portion has a first terminal end configured to pierce the tissue, and wherein the second securing state comprises at least a section of the first portion of the body assuming a curved geometry embedded in the tissue and at least a section of the medial portion of the body assuming a curved geometry around a surface of the article, releasably engaging the securing device in the first deployment state within the system for securing the article, engaging, by least a portion of the distal end of the housing, the article with the surface of the tissue, releasing the securing device from the distal end of the housing, thereby allowing the body to assume the second securing state and securing the article against the surface of the tissue.
In some applications, there may be a need to attach an article to a tissue, and especially a need for the article to be in close proximity to (for example, in physical contact with) the tissue. In many surgical procedures, articles may be secured through the use of one or more sutures, staples, and clamps. Sutures may be used in a wide variety of procedures because sutures, comprising flexible material, may take on the shape of the surface of the article being attached. However, suturing is a time-consuming process, and there may be variability in the degree of stabilization of the article to the tissue surface due to the innate variability of suture application. Additionally, the flexible suturing material may have a limited tensile strength that may not be strong enough for some applications.
Staples and clips may require less time to apply. Staplers, used to apply the staples, may provide more consistent force for securing the article to the tissue. As a result, there is less variability in force applied to the article, especially if a number of staples are used. Such staples and clips are typically made of metal, which has a greater tensile strength than sutures. However, staples and clips, because they are more rigid than sutures, may not readily conform to the surface of the article being secured. As a result, the article secured by the staples or clips may shift because the clip/article interface is not exact.
Disclosed herein is a device for securing an article to a tissue in which the device combines useful features of both sutures and staples. Specifically, the securing device disclosed herein may adjust to the surface geometry of the article being secured while being easily applied from a stapler-type system. In some examples, the article may include one or more cardiovascular implant articles. In some examples, the tissue may comprise a soft tissue such as one or more of a muscle tissue, a tendon tissue, a ligament tissue, and a cardiovascular tissue.
In some applications, the device may place the article in close proximity to the tissue. Alternatively, the device may be used to cause the article to physically contact the tissue. In some alternative applications, the securing device may be used to secure two portions of tissue together with or without securing a non-tissue article thereto.
Additionally, a system for deploying the device is disclosed herein. In some embodiments, the system may be an arthroscopic delivery device or may be part of an arthroscopic device. Such arthroscopic devices may be used, for example, during open surgical procedures or in minimally invasive surgical procedures. In some medical procedures, it may be necessary to visualize the attachment of the device to the tissue and article. Examples of visualization methods may include radiographic methods and ultrasound methods. The device disclosed herein generally has a two dimensional design and function, thereby accommodating such visualization techniques.
The disclosed device can be used in a variety of procedures in which one or more devices and/or one or more tissues may be involved. In one example, an article may be partially pre-attached to a tissue by an alternative means, such as by gluing, and a more robust attachment is required. In another example, the article may be in physical proximity to the tissue but may lack any secure attachment. In yet another example, the article may be completely attached to the tissue and additional locking between the article and the tissue may be required.
In one non-limiting example, the article may include one or more sutures or polymers and the tissue may include one of the papillary muscles. Such a procedure may find use in repairing or replacing one or more of the chordae tendineae by providing an anchor for the suture or polymer in the muscle to which the replacement may be attached.
The disclosed device can also be used as a means to attach two articles together. In one non-limiting embodiment, the first article may be a previously implanted article already fixed at a target site and the second article may be a new structure to be fixed to the first article and/or the surrounding tissue. As a non-limiting example, the first article may be a D-shaped or round annuloplasty ring that is implanted in a mitral valve annulus, and the second article may include a prosthetic valve designed to work in concert with the annuloplasty ring.
As disclosed herein, the securing device may take on a variety of embodiments as depicted in
Such securing devices may derive their property of transitioning from a first geometric state to a second geometric state from the material or materials from which they are made. In particular, the securing devices disclosed herein may comprise one or more materials having a high yield stress and high level of recoverable plastic strain. As a result of these properties, the device may be deformed from its relaxed shape (comprising the securing state) into a second shape (the deployment state) under force, but will return to the original relaxed shape once the force is removed.
In some non-limiting examples, the body of the securing device may include one or more of a metal, a polymer, and a plastic. Non-limiting examples of such metals may include 316 stainless steel, a cobalt chromium alloy, and combinations and alloys thereof. In some non-limiting examples, the body of the securing device may include one or more of a biocompatible material and a bio-absorbable material. In some non-limiting examples, the biocompatible material may include polyether ether ketone, a polyetherimide, or similar material. In some non-limiting examples, the body of the securing device may include one or more of a superelastic material and a shape memory alloy. A non-limiting example of such a shape memory alloy may include a nickel titanium alloy.
In addition to the materials to provide appropriate material properties, the securing devices may also include materials specific for the securing device function or use. Thus, in some embodiments, at least a portion of the body of the securing device may include a material that is visualizable by a radiological technique, an MRI technique, and an ultrasound technique.
In general, there are no limitations to any one or more of the physical dimensions of the securing device, as the dimensions of any one securing device may depend, at least in part, on the article to be secured, the tissue to which it may be secured, and the system used to deploy the securing device and secure the article. In one embodiment, the body of the securing device may have a length of about 10 mm to about 30 mm. Examples of the body length of the securing device may include a length of about 10 mm, about 12 mm, about 14 mm, about 16 mm, about 18 mm, about 20 mm, about 22 mm, about 24 mm, about 26 mm, about 28 mm, about 30 mm, and any value or range between any two of these values including endpoints. In one non-limiting example, the body of the securing device may have a length of about 20 mm. In some securing devices, the body may have a cross-sectional diameter of about 0.2 mm to about 1 mm. Examples of the body cross-sectional diameter of the securing device may include a diameter of about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, about 1 mm, and any value or range between any two of these values including endpoints. In one non-limiting example, the body of the securing device may have a cross-sectional diameter of about 0.5 mm.
In some embodiments, at least a portion of the body of the securing device may have a circular cross-section. In some securing devices, the body may have a circular cross-sectional diameter of about 0.2 mm to about 1.5 mm. Examples of the circular cross-sectional diameter of the securing device may include a diameter of about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, about 1 mm, about 1.3 mm, about 1.5 mm, and any value or range between any two of these values including endpoints. In one non-limiting example, the body of the securing device may have a circular cross-sectional diameter of about of about 0.8 mm.
In some embodiments, at least a portion of the body of the securing device may have a square or rectangular cross section. In some securing devices, the body may have a rectangular cross-section having a first cross-sectional diameter of about 0.2 mm to about 1 mm and a second cross-sectional diameter of about 0.2 mm to about 1 mm. Examples of the first cross-sectional diameter of the securing device may include a diameter of about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, about 1 mm, and any value or range between any two of these values including endpoints. Examples of the second cross-sectional diameter of the securing device may include a diameter of about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, about 1 mm, and any value or range between any two of these values including endpoints. In one non-limiting example, a securing device having a rectangular cross-section may have a first cross-sectional diameter of about 0.5 mm and a second cross-sectional diameter of about 0.8 mm.
As depicted in
In some non-limiting examples, the tab 11a may have a length of about 2 mm to about 7 mm. Examples of the length of the tab 11a may include a length of about 2 mm, about 3 mm, about 4 mm, about 5 mm, about 6 mm, about 7 mm, and any value or range between any two of these values including endpoints. In one non-limiting example, the tab 11a may have a length of about 5 mm. In some non-limiting examples, the tab 11a may have a width of about 0.2 mm to about 1 mm. Examples of the width of the tab 11a may include a width of about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, about 1 mm, and any value or range between any two of these values including endpoints. In one non-limiting example, the tab 11a may have a width of about 0.5 mm. In some non-limiting examples, the tab 11a may be displaced from the medial portion 13a of the body of the securing device by a slot 15a having by a distance of about 0.5 mm to about 3 mm from the medial portion. Examples of the distance of the tab 11a from the medial portion 13a of the body may include a distance of about 0.5 mm, about 1 mm, about 1.5 mm, about 2 mm, about 2.5 mm, about 3 mm, and any value or range between any two of these values including endpoints. In one non-limiting example, the tab 11a may have distance from the medial portion 13a of the body of about 1.5 mm.
The securing device in the deployment state 10a may also include a friction protrusion 16a in mechanical communication with the medial portion of the body 13a and proximate to the tab 11a. In some embodiments, the tab 11a may have a first end in mechanical communication with the tab standoff 17a and have a second free end approximately opposite the friction protrusion 16a without making physical contact with it. In some alternative embodiments, the second free end of the tab 11a may be in mechanical contact with the friction protrusion 16a. The friction protrusion 16a and the tab 11a may help secure the securing device in the extended state 10a to a system configured to deploy it, as disclosed below.
In some non-limiting embodiments, the friction protrusion 16a may have a height of about 0.2 mm to about 1 mm. Examples of the height of the friction protrusion 16a may include a height of about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, about 1 mm, and ranges between any two of these values including endpoints. In one non-limiting example, the friction protrusion 16a may have a height of about 0.5 mm.
As depicted in
As depicted in
As depicted in
It may be appreciated that securing devices having parallel first and second portions in the deployment state may assume any of a number of different geometries in the securing state. For example, as depicted in
The system may include an exterior tube 31 that may house the remaining components. In one embodiment, the exterior tube 31 may include, at a distal end, a portion configured to form a mechanically stable contact between the article 2 and the surface of the tissue 3. In one non-limiting example, the portion of the exterior tube 31 may comprise a pawl 32. The pawl 32 may have a surface geometry complementary to the geometry of at least a portion of an external surface of the article 2. The exterior tube 31 may be composed of one or more of a metal and a plastic. In some embodiments, the exterior tube 31 may be composed of one or more of a stainless steel, a nickel titanium alloy, and a cobalt chrome alloy. In some embodiments, the exterior tube 31 may be composed of one or more of a polyether ether ketone, a polyether block amide, a polytetrafluoroethylene, a fluorinated ethylene propylene, and an extended polytetrafluoroethylene.
In general, there are no limitations to any one or more of the physical dimensions of the system, as the dimensions of the system may depend, at least in part, on the article to be secured, the tissue to which it may be secured, and the securing device. In some non-limiting embodiments, the exterior tube 31 may have a diameter of about 3 mm to about 8 mm. Examples of the diameter of the exterior tube 31 may include a diameter of about 3 mm, about 4 mm, about 5 mm, about 6 mm, about 7 mm, about 8 mm, and any value or range between any two of these values including endpoints. In one non-limiting example, the exterior tube 31 may have a diameter of about 5 mm.
The system may also include a medial tube 34 disposed at least partially within the exterior tube 31, an interior tube 36 at least partially disposed within the medial tube, and a push rod 38 at least partially disposed within the interior tube.
The medial tube 34 may be composed of one or more of a metal and a plastic. In some non-limiting examples, the medial tube 34 may be composed of one or more of a stainless steel, a nickel titanium alloy, and a cobalt chrome alloy. In some other non-limiting examples, the medial tube 34 may be composed of or more of a polyether ether ketone, a polyether block amide, a polytetrafluoroethylene, a fluorinated ethylene propylene, and an extended polytetrafluoroethylene.
The interior tube 36 may be composed of one or more of a metal and a plastic. In some non-limiting examples, the medial tube 36 may be composed of one or more of a stainless steel, a nickel titanium alloy, and a cobalt chrome alloy. In some other non-limiting examples, the medial tube 36 may be composed of or more of a polyether ether ketone, a polyether block amide, a polytetrafluoroethylene, a fluorinated ethylene propylene, and an extended polytetrafluoroethylene.
The push rod 38 may be composed of a metal. In some non-limiting examples, the push rod 38 may be composed of one or more of a stainless steel, a nickel titanium alloy, and a cobalt chrome alloy.
As depicted in
The securing device and system depicted in
An alternative embodiment of a system for securing an article to a tissue is depicted in
The method may also include providing 620 at least one securing device. In some embodiments, the at least one securing device may include a body, transitionable from a first deployment state to a second securing state, having a first portion, a second portion, and a medial portion between the first portion and the second portion. The first portion of the securing device may further have a first terminal end configured to pierce the tissue. Additionally, the second securing state of the securing device may include at least a section of the first portion of the body assuming a curved geometry embedded in the tissue and at least a section of the medial portion of the body contacting a surface of the article.
In one non-limiting example, the first deployment state of the securing device may take the form of a U-shaped state, and the second securing state may include at least a section of a first terminal end of the first portion assuming a curved geometry embedded in the tissue, at least a section of a second terminal end of the second portion assuming a curved geometry embedded in the tissue, and at least a section of the medial portion contacting a surface of the article
In another non-limiting example, the first deployment state of the securing device may take the form of a linearly extended state, and the second securing state may further include at least a section of the first portion of the body assuming a curved geometry embedded in the tissue and at least a section of the second portion contacting a surface of the article. In some additional non-limiting examples, the securing device may further include a tab standoff in mechanical communication with the medial portion of the body at a first standoff end and a tab at a second standoff end, in which the tab may be displaced by a slot from the body.
The securing device, while in a deployment state, may be releasably engaged 630 with the deployment system. In some embodiments, the at least one securing device may include a tab standoff in mechanical communication with the medial portion of the body of the securing device at a first standoff end and a tab at a second standoff end, thereby displacing the tab from the body by a slot. For such a securing device, releasably engaging 630 the device within the system for securing the article may further include releasably engaging the slot of the device with a portion of the deployment system. In one example, such a deployment system may include an interior tube having a distal end that may engage 630 the slot of the securing device.
In some embodiments, the at least one securing device may also include a friction protrusion in mechanical communication with the body and proximate to a tab. For such a securing device, releasably engaging the device within the system for securing the article may further include releasably engaging the friction protrusion with a detent on an exterior surface of an interior tube of the deployment system.
The deployment system may be used to engage 640 the article with the surface of the tissue. In some embodiments, the article may be engaged 640 with the surface of the tissue using at least a portion of a distal end of the housing.
The securing device may be released 650 from the deployment system, thereby allowing the body of the securing device to assume the second securing state and securing the article against the surface of the tissue. In some non-limiting embodiments, releasing 650 the securing device from the distal end of the housing may include contacting the tab of the securing device with a distal end of a deployment system push rod, extending the push rod in a distal direction, and extending a medial tube of the deployment system in a proximal direction.
In the above detailed description, reference is made to the accompanying drawings, which form a part hereof. In the drawings, similar symbols typically identify similar components, unless context dictates otherwise. The illustrative embodiments described in the detailed description, drawings, and claims are not meant to be limiting. Other embodiments may be used, and other changes may be made, without departing from the spirit or scope of the subject matter presented herein. It will be readily understood that the aspects of the present disclosure, as generally described herein, and illustrated in the Figures, can be arranged, substituted, combined, separated, and designed in a wide variety of different configurations, all of which are explicitly contemplated herein.
The present disclosure is not to be limited in terms of the particular embodiments described in this application, which are intended as illustrations of various aspects. Many modifications and variations can be made without departing from its spirit and scope, as will be apparent to those skilled in the art. Functionally equivalent methods and apparatuses within the scope of the disclosure, in addition to those enumerated herein, will be apparent to those skilled in the art from the foregoing descriptions. Such modifications and variations are intended to fall within the scope of the appended claims. The present disclosure is to be limited only by the terms of the appended claims, along with the full scope of equivalents to which such claims are entitled. It is to be understood that this disclosure is not limited to particular methods, reagents, compounds, compositions or biological systems, which can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.
With respect to the use of substantially any plural and/or singular terms herein, those having skill in the art can translate from the plural to the singular and/or from the singular to the plural as is appropriate to the context and/or application. The various singular/plural permutations may be expressly set forth herein for sake of clarity.
It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (for example, bodies of the appended claims) are generally intended as “open” terms (for example, the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” et cetera). While various compositions, methods, and devices are described in terms of “comprising” various components or steps (interpreted as meaning “including, but not limited to”), the compositions, methods, and devices can also “consist essentially of” or “consist of” the various components and steps, and such terminology should be interpreted as defining essentially closed-member groups. It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (for example, “a” and/or “an” should be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should be interpreted to mean at least the recited number (for example, the bare recitation of “two recitations,” without other modifiers, means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, et cetera” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (for example, “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, et cetera). In those instances where a convention analogous to “at least one of A, B, or C, et cetera” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (for example, “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, et cetera). It will be further understood by those within the art that virtually any disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” will be understood to include the possibilities of “A” or “B” or “A and B.”
In addition, where features or aspects of the disclosure are described in terms of Markush groups, those skilled in the art will recognize that the disclosure is also thereby described in terms of any individual member or subgroup of members of the Markush group.
As will be understood by one skilled in the art, for any and all purposes, such as in terms of providing a written description, all ranges disclosed herein also encompass any and all possible subranges and combinations of subranges thereof. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds, quarters, fifths, tenths, et cetera As a non-limiting example, each range discussed herein can be readily broken down into a lower third, middle third and upper third, et cetera As will also be understood by one skilled in the art all language such as “up to,” “at least,” and the like include the number recited and refer to ranges which can be subsequently broken down into subranges as discussed above. Finally, as will be understood by one skilled in the art, a range includes each individual member. Thus, for example, a group having 1-3 cells refers to groups having 1, 2, or 3 cells. Similarly, a group having 1-5 cells refers to groups having 1, 2, 3, 4, or 5 cells, and so forth.
Various of the above-disclosed and other features and functions, or alternatives thereof, may be combined into many other different systems or applications. Various presently unforeseen or unanticipated alternatives, modifications, variations or improvements therein may be subsequently made by those skilled in the art, each of which is also intended to be encompassed by the disclosed embodiments.
This application is a divisional of U.S. application Ser. No. 14/897,921, entitled “DEVICE, SYSTEM, AND METHOD TO SECURE AN ARTICLE TO A TISSUE,” filed Dec. 11, 2015, which is a U.S. national stage filing under 35 U.S.C. § 371 of International Application No. PCT/US2014/044920 entitled “DEVICE, SYSTEM, AND METHOD TO SECURE AN ARTICLE TO A TISSUE,” filed Jun. 30, 2014, which claims benefit of and priority to U.S. Provisional Patent Application No. 61/840,588, entitled “STAPLE AND METHOD TO DELIVER IT TO A TARGET SITE,” filed Jun. 28, 2013, the disclosures of which are incorporated herein by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 4602911 | Ahmadi et al. | Jul 1986 | A |
| 5236440 | Hlavacek | Aug 1993 | A |
| 5306296 | Wright et al. | Apr 1994 | A |
| 5695518 | Laerum | Dec 1997 | A |
| 5716370 | Williamson, IV et al. | Feb 1998 | A |
| 5855614 | Stevens et al. | Jan 1999 | A |
| 6113611 | Allen et al. | Sep 2000 | A |
| 6231602 | Carpentier et al. | May 2001 | B1 |
| 6447524 | Knodel et al. | Sep 2002 | B1 |
| 6619291 | Hlavka et al. | Sep 2003 | B2 |
| 6629534 | St. Goar et al. | Oct 2003 | B1 |
| 6669687 | Saadat | Dec 2003 | B1 |
| 6689048 | Vanden Hoek et al. | Feb 2004 | B2 |
| 6726704 | Loshakove et al. | Apr 2004 | B1 |
| 6776784 | Ginn | Aug 2004 | B2 |
| 6790229 | Berreklouw | Sep 2004 | B1 |
| 6797002 | Spence et al. | Sep 2004 | B2 |
| 6805711 | Quijano et al. | Oct 2004 | B2 |
| 6893459 | Macoviak | May 2005 | B1 |
| 7101395 | Tremulis et al. | Sep 2006 | B2 |
| 7114953 | Wagner | Oct 2006 | B1 |
| 7175660 | Cartledge et al. | Feb 2007 | B2 |
| 7238191 | Bachmann | Jul 2007 | B2 |
| 7285087 | Moaddeb et al. | Oct 2007 | B2 |
| 7297150 | Cartledge et al. | Nov 2007 | B2 |
| 7569072 | Berg et al. | Aug 2009 | B2 |
| 7594887 | Moaddeb et al. | Sep 2009 | B2 |
| 7635329 | Goldfarb et al. | Dec 2009 | B2 |
| 7655040 | Douk et al. | Feb 2010 | B2 |
| 7717954 | Solem et al. | May 2010 | B2 |
| 7722668 | Moaddeb et al. | May 2010 | B2 |
| 7758637 | Starksen et al. | Jul 2010 | B2 |
| 7837729 | Gordon et al. | Nov 2010 | B2 |
| 7988725 | Gross et al. | Aug 2011 | B2 |
| 8163014 | Lane et al. | Apr 2012 | B2 |
| 8182529 | Gordon et al. | May 2012 | B2 |
| 8236049 | Rowe et al. | Aug 2012 | B2 |
| 8287591 | Keidar et al. | Oct 2012 | B2 |
| 8518107 | Tsukashima et al. | Aug 2013 | B2 |
| 8579968 | Shannon et al. | Nov 2013 | B1 |
| 20020151961 | Lashinski et al. | Oct 2002 | A1 |
| 20020151970 | Garrison et al. | Oct 2002 | A1 |
| 20020188170 | Santamore et al. | Dec 2002 | A1 |
| 20020198526 | Shaolian et al. | Dec 2002 | A1 |
| 20030050693 | Quijano et al. | Mar 2003 | A1 |
| 20030078465 | Pai et al. | Apr 2003 | A1 |
| 20030078671 | Lesniak et al. | Apr 2003 | A1 |
| 20030191528 | Quijano et al. | Oct 2003 | A1 |
| 20030198605 | Montgomery | Oct 2003 | A1 |
| 20030199974 | Lee et al. | Oct 2003 | A1 |
| 20040044364 | DeVries et al. | Mar 2004 | A1 |
| 20040068276 | Golden et al. | Apr 2004 | A1 |
| 20040122514 | Fogarty et al. | Jun 2004 | A1 |
| 20040138744 | Lashinski et al. | Jul 2004 | A1 |
| 20040148021 | Cartledge et al. | Jul 2004 | A1 |
| 20040193191 | Starksen et al. | Sep 2004 | A1 |
| 20040243230 | Navia et al. | Dec 2004 | A1 |
| 20040249391 | Cummins | Dec 2004 | A1 |
| 20040260393 | Rahdert et al. | Dec 2004 | A1 |
| 20040260394 | Douk et al. | Dec 2004 | A1 |
| 20050020696 | Montgomery et al. | Jan 2005 | A1 |
| 20050033325 | May et al. | Feb 2005 | A1 |
| 20050065550 | Starksen et al. | Mar 2005 | A1 |
| 20050090846 | Pedersen et al. | Apr 2005 | A1 |
| 20050096740 | Langberg et al. | May 2005 | A1 |
| 20050113910 | Paniagua et al. | May 2005 | A1 |
| 20050137692 | Haug et al. | Jun 2005 | A1 |
| 20050137695 | Salahieh et al. | Jun 2005 | A1 |
| 20050203549 | Realyvasquez | Sep 2005 | A1 |
| 20050222678 | Lashinski et al. | Oct 2005 | A1 |
| 20050240200 | Bergheim | Oct 2005 | A1 |
| 20050267572 | Schoon et al. | Dec 2005 | A1 |
| 20050283190 | Huitema et al. | Dec 2005 | A1 |
| 20050288778 | Shaoulian et al. | Dec 2005 | A1 |
| 20050288781 | Moaddeb et al. | Dec 2005 | A1 |
| 20060009737 | Whiting et al. | Jan 2006 | A1 |
| 20060020327 | Lashinski et al. | Jan 2006 | A1 |
| 20060122633 | To et al. | Jun 2006 | A1 |
| 20060129025 | Levine et al. | Jun 2006 | A1 |
| 20060155165 | Hoek et al. | Jul 2006 | A1 |
| 20060161169 | Nieminen et al. | Jul 2006 | A1 |
| 20060184240 | Jimenez et al. | Aug 2006 | A1 |
| 20060184242 | Lichtenstein | Aug 2006 | A1 |
| 20060195134 | Crittenden | Aug 2006 | A1 |
| 20060195183 | Navia et al. | Aug 2006 | A1 |
| 20060241748 | Lee et al. | Oct 2006 | A1 |
| 20060282161 | Huynh et al. | Dec 2006 | A1 |
| 20070016287 | Cartledge et al. | Jan 2007 | A1 |
| 20070027533 | Douk | Feb 2007 | A1 |
| 20070038296 | Navia et al. | Feb 2007 | A1 |
| 20070051377 | Douk et al. | Mar 2007 | A1 |
| 20070067027 | Moaddeb et al. | Mar 2007 | A1 |
| 20070073098 | Lenker et al. | Mar 2007 | A1 |
| 20070080188 | Spence et al. | Apr 2007 | A1 |
| 20070093854 | Kayan | Apr 2007 | A1 |
| 20070118215 | Moaddeb | May 2007 | A1 |
| 20070128132 | Piergallini et al. | Jun 2007 | A1 |
| 20070135913 | Moaddeb et al. | Jun 2007 | A1 |
| 20070142907 | Moaddeb et al. | Jun 2007 | A1 |
| 20070213812 | Webler et al. | Sep 2007 | A1 |
| 20070233239 | Navia et al. | Oct 2007 | A1 |
| 20070239272 | Navia et al. | Oct 2007 | A1 |
| 20070244553 | Rafiee et al. | Oct 2007 | A1 |
| 20070244554 | Rafiee et al. | Oct 2007 | A1 |
| 20070244555 | Rafiee et al. | Oct 2007 | A1 |
| 20070244556 | Rafiee et al. | Oct 2007 | A1 |
| 20070250161 | Dolan | Oct 2007 | A1 |
| 20070293942 | Mirzaee | Dec 2007 | A1 |
| 20080177380 | Starksen et al. | Jul 2008 | A1 |
| 20080177381 | Navia et al. | Jul 2008 | A1 |
| 20080200980 | Robin et al. | Aug 2008 | A1 |
| 20080243220 | Barker | Oct 2008 | A1 |
| 20080262513 | Stahler et al. | Oct 2008 | A1 |
| 20080262609 | Gross et al. | Oct 2008 | A1 |
| 20080306586 | Cartledge et al. | Dec 2008 | A1 |
| 20090088838 | Shaolian et al. | Apr 2009 | A1 |
| 20090118747 | Bettuchi et al. | May 2009 | A1 |
| 20090125098 | Chuter | May 2009 | A1 |
| 20090149872 | Gross et al. | Jun 2009 | A1 |
| 20090216322 | Le et al. | Aug 2009 | A1 |
| 20090222083 | Nguyen et al. | Sep 2009 | A1 |
| 20090238778 | Mordas et al. | Sep 2009 | A1 |
| 20090299470 | Rao et al. | Dec 2009 | A1 |
| 20100010616 | Drews et al. | Jan 2010 | A1 |
| 20100030014 | Ferrazzi | Feb 2010 | A1 |
| 20100063586 | Hasenkam et al. | Mar 2010 | A1 |
| 20100121433 | Bolling et al. | May 2010 | A1 |
| 20100161047 | Cabiri | Jun 2010 | A1 |
| 20100185274 | Moaddeb et al. | Jul 2010 | A1 |
| 20100211166 | Miller et al. | Aug 2010 | A1 |
| 20100249920 | Bolling et al. | Sep 2010 | A1 |
| 20100266989 | Piergallini et al. | Oct 2010 | A1 |
| 20100280605 | Hammer et al. | Nov 2010 | A1 |
| 20100286767 | Zipory et al. | Nov 2010 | A1 |
| 20110022168 | Cartledge | Jan 2011 | A1 |
| 20110027753 | Maurat et al. | Feb 2011 | A1 |
| 20110034953 | Milo | Feb 2011 | A1 |
| 20110066231 | Cartledge et al. | Mar 2011 | A1 |
| 20110093062 | Cartledge et al. | Apr 2011 | A1 |
| 20110106245 | Miller et al. | May 2011 | A1 |
| 20110106247 | Miller et al. | May 2011 | A1 |
| 20110137397 | Chau et al. | Jun 2011 | A1 |
| 20110166649 | Gross et al. | Jul 2011 | A1 |
| 20110190879 | Bobo et al. | Aug 2011 | A1 |
| 20110208298 | Tuval et al. | Aug 2011 | A1 |
| 20110224785 | Hacohen | Sep 2011 | A1 |
| 20110257728 | Kuehn | Oct 2011 | A1 |
| 20110282361 | Miller et al. | Nov 2011 | A1 |
| 20110301698 | Miller et al. | Dec 2011 | A1 |
| 20110301699 | Saadat | Dec 2011 | A1 |
| 20120022557 | Cabiri et al. | Jan 2012 | A1 |
| 20120022644 | Reich et al. | Jan 2012 | A1 |
| 20120059458 | Buchbinder et al. | Mar 2012 | A1 |
| 20120095455 | Rodmond et al. | Apr 2012 | A1 |
| 20120123531 | Tsukashima et al. | May 2012 | A1 |
| 20120136436 | Cabiri et al. | May 2012 | A1 |
| 20120165930 | Gifford, III et al. | Jun 2012 | A1 |
| 20120245604 | Tegzes | Sep 2012 | A1 |
| 20120310330 | Buchbinder et al. | Dec 2012 | A1 |
| 20130087598 | Surti | Apr 2013 | A1 |
| 20130116780 | Miller et al. | May 2013 | A1 |
| 20130166022 | Conklin | Jun 2013 | A1 |
| 20130204361 | Adams et al. | Aug 2013 | A1 |
| 20130226289 | Shaolian et al. | Aug 2013 | A1 |
| 20130226290 | Yellin et al. | Aug 2013 | A1 |
| 20130282114 | Schweich, Jr. et al. | Oct 2013 | A1 |
| 20130289718 | Tsukashima et al. | Oct 2013 | A1 |
| 20130289720 | Dobrilovic | Oct 2013 | A1 |
| 20130304197 | Buchbinder et al. | Nov 2013 | A1 |
| 20140005778 | Buchbinder et al. | Jan 2014 | A1 |
| 20140046433 | Kovalsky | Feb 2014 | A1 |
| 20140058505 | Bielefeld | Feb 2014 | A1 |
| 20140114407 | Rajamannan | Apr 2014 | A1 |
| 20150173897 | Raanani et al. | Jun 2015 | A1 |
| 20150173987 | Albinmousa et al. | Jun 2015 | A1 |
| 20150351903 | Morriss et al. | Dec 2015 | A1 |
| 20160022419 | Yellin et al. | Jan 2016 | A1 |
| 20160038286 | Yellin et al. | Feb 2016 | A1 |
| 20160089235 | Yellin | Mar 2016 | A1 |
| 20160106420 | Foerster et al. | Apr 2016 | A1 |
| 20160120642 | Shaolian et al. | May 2016 | A1 |
| 20160120645 | Alon | May 2016 | A1 |
| 20170042670 | Shaolian et al. | Feb 2017 | A1 |
| 20170231763 | Yellin | Aug 2017 | A1 |
| 20180042723 | Yellin et al. | Feb 2018 | A1 |
| 20190083091 | Foerster | Mar 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 102014102653 | Sep 2015 | DE |
| 2600799 | Jun 2013 | EP |
| 2967700 | Jan 2016 | EP |
| 20040095482 | Nov 2004 | KR |
| 125062 | Feb 2013 | RU |
| 199009153 | Aug 1990 | WO |
| 2003017874 | Mar 2003 | WO |
| 2003047467 | Jun 2003 | WO |
| 2005046488 | May 2005 | WO |
| 2009052427 | Apr 2009 | WO |
| 2009120764 | Oct 2009 | WO |
| 2010004546 | Jan 2010 | WO |
| 2010085659 | Jul 2010 | WO |
| 2011011443 | Jan 2011 | WO |
| 2011097355 | Aug 2011 | WO |
| 2012004679 | Jan 2012 | WO |
| 2012019052 | Feb 2012 | WO |
| 2012063228 | May 2012 | WO |
| 2012095159 | Jul 2012 | WO |
| 2012106354 | Aug 2012 | WO |
| 2012167095 | Dec 2012 | WO |
| 2013095816 | Jun 2013 | WO |
| 2013128436 | Sep 2013 | WO |
| 2013130641 | Sep 2013 | WO |
| 2013175468 | Nov 2013 | WO |
| 2014145399 | Sep 2014 | WO |
| 2014178869 | Nov 2014 | WO |
| 2014189509 | Nov 2014 | WO |
| 2014190329 | Nov 2014 | WO |
| 2014210600 | Dec 2014 | WO |
| 2015132668 | Sep 2015 | WO |
| 2018035118 | Feb 2018 | WO |
| Entry |
|---|
| Communication pursuant to Article 94(3) EPC for EP 14801009.3 dated Sep. 27, 2018. |
| International Search Report and Written Opinion for PCT2019/064289 dated Feb. 5, 2020. |
| European Search Report in EP 17155803.4 dated Aug. 9, 2017. |
| International Search Report and Written Opinion for PCT/US2014/044920 dated Dec. 24, 2014. |
| International Search Report and Written Opinion for PCT/US2011/046659 dated Jun. 4, 2012. |
| International Search Report and Written Opinion for PCT/US2012/040481 dated Dec. 6, 2012. |
| International Search Report and Written Opinion for PCT/US2013/042275 dated Feb. 20, 2014. |
| International Search Report and Written Opinion for PCT/US2013/073552 dated Mar. 6, 2014. |
| International Search Report and Written Opinion for PCT/US2014/039545 dated Oct. 22, 2014. |
| International Search Report and Written Opinion for PCT/US2014/030163 dated Aug. 27, 2014. |
| International Search Report and Written Opinion for PCT/US2013/058102 dated Apr. 21, 2014. |
| International Search Report for PCT/US2013/028065 dated Jun. 27, 2013. |
| Lendlein et al. Biodegradable, Elastic Shape-Memory Polymers for Potential Biomedical Applications (May 31, 2002), Science 296:1673-1676. |
| Supplemental European Search Report and Written Opinion for EP 12793292.9 dated Dec. 1, 2014. |
| Supplemental European Search Report and Written Opinion for EP 14762806.9 dated Jul. 29, 2016. |
| Supplementary Partial European Search Report for EP 13755441 dated Nov. 3, 2015. |
| International Search Report and Written Opinion for PCT/US17/46933 dated Dec. 21, 2017. |
| International Search Report and Written Opinion for PCT/US2018/022910 dated May 23, 2018. |
| U.S. Appl. No. 14/897,921, et al., Notice of Allowance , dated Mar. 18, 2021 ,9 pages. |
| 14817662.1, Extended European Search Report , dated Jan. 23, 2017, 7 pages. |
| PCT/US2014/039454, International Search Report and Written Opinion , dated Oct. 22, 2014, 10 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20190083092 A1 | Mar 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61840588 | Jun 2013 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14897921 | US | |
| Child | 16196444 | US |
